Akso Health Group (AHG)
NASDAQ: AHG
· Real-Time Price · USD
1.77
0.03 (1.72%)
At close: Aug 15, 2025, 3:00 PM
Akso Health Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 760.38K | 760.38K | 446.79K | 446.79K | 662.24K | 662.24K | 5.93M | 5.93M | 2.72M | 3.03M | 122.96K | 122.96K | -1.55M | 200.86K | 676.61K | 676.61K |
Cost of Revenue | 718.73K | 718.73K | 427.38K | 427.38K | 590.68K | 590.68K | 5.37M | 5.37M | 180.4K | n/a | 840.23K | n/a | 5.77M | 6.44M | 1.46M | 6.44M |
Gross Profit | 41.65K | 41.65K | 19.41K | 19.41K | 71.56K | 71.56K | 562.94K | 562.94K | 6,311.1B | 3.03M | -594.31K | 122.96K | -17.63M | -6.24M | -103.38K | -5.76M |
Operating Income | -3.16M | -3.16M | -1.16M | -1.16M | -7.02M | -7.02M | -110.08K | -110.08K | 20.39M | -3.63M | -8.92M | -3.93M | -10.51M | -5.84M | -23.59M | -7.74M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 102.07K | 300K | 300K | n/a | 497.84K | 579.47K | 579.47K |
Pretax Income | -3.03M | -3.03M | -1.52M | -1.52M | -7.36M | -7.36M | 829.3K | 829.31K | 18.33M | -3.91M | -0.53 | -4.45M | -12.74M | -6.81M | -1.45 | -8.72M |
Net Income | -3M | -3M | -1.53M | -1.53M | -7.41M | -7.41M | 815.38K | 815.38K | 14.71M | -3.97M | 16.89M | -4.46M | -20.12M | -7.02M | 16.3M | -8.76M |
Selling & General & Admin | 3.2M | 3.2M | 1.18M | 1.18M | 7.09M | 7.09M | 673.02K | 673.02K | 6.5M | 1.45M | 4.06M | 4.06M | 1.35M | 12.48M | 1.98M | 1.98M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.7K | 112.65K | 112.65K | 220.7K | 220.7K | n/a | n/a |
Other Expenses | n/a | n/a | -3.4 | n/a | -10.47 | n/a | 0.07 | n/a | -1.29 | n/a | -36.18 | n/a | 4.35M | n/a | -12.89 | n/a |
Operating Expenses | 3.2M | 3.07M | 1.54M | 1.54M | 7.43M | 7.43M | 266.36K | 266.36K | -26.95M | 1.63M | 4.27M | 4.27M | 5.7M | 12.96M | 2.38M | 2.38M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 84.21K | 84.21K | n/a | n/a | 46.8K | 46.8K | 50.13K | 50.13K | 529.33K | 42.3K | 78.16K | 78.16K | 822.22K | 264.79K | 278.71K | 278.71K |
Cost & Expenses | 3.92M | 3.79M | 1.97M | 1.97M | 8.02M | 8.02M | 5.63M | 5.63M | -21.18M | 1.63M | 4.27M | 4.27M | 11.48M | 19.4M | 8.82M | 8.82M |
Income Tax Expense | 59.00 | 59.00 | 12.44K | 12.44K | 2.9K | 2.9K | 5.87K | 5.87K | 3.62M | 56.77K | -0.53 | 8.95K | 4.1M | 204.47K | -1.45 | 37.02K |
Shares Outstanding (Basic) | 20.81M | 20.79M | 7.62M | 7.62M | 7.42M | 7.42M | 8.25M | 8.25M | 6.62M | 6.06M | 5.5M | 5.5M | 5.43M | 5.42M | 5.43M | 5.43M |
Shares Outstanding (Diluted) | 23.83M | 23.83M | 7.62M | 7.62M | 7.62M | 7.62M | 7.62M | 7.62M | 6.62M | 6.13M | 5.63M | 5.63M | 5.43M | 5.42M | 5.43M | 5.43M |
EPS (Basic) | -0.14 | -0.14 | -0.2 | -0.2 | -0.99 | -0.99 | 0.10 | 0.10 | 2.22 | -0.66 | 3.06 | -0.81 | -3.72 | -1.29 | 3.00 | -1.62 |
EPS (Diluted) | -0.13 | -0.13 | -0.2 | -0.2 | -0.96 | -0.96 | 0.11 | 0.11 | 2.22 | -0.66 | 3.00 | -0.78 | -3.72 | -1.29 | 3.00 | -1.62 |
EBITDA | n/a | n/a | n/a | n/a | -7.02M | -7.02M | -103.16K | -103.16K | 9.05M | -3.62M | -3.93M | -3.93M | 19.23M | -5.81M | -7.59M | -7.59M |
EBIT | -3.16M | -3.16M | -1.16M | -1.16M | -7.02M | -7.02M | -110.08K | -110.08K | 9.05M | -3.63M | -3.93M | -3.93M | 19.23M | -5.84M | -7.74M | -7.74M |
Depreciation & Amortization | 3.16M | 3.16M | 1.16M | 1.16M | 4.6K | 6.92K | 6.92K | 6.92K | -7.76M | 7.34K | -8.9M | 2.01K | -13.18M | 30.13K | -17.44M | 145.13K |